Market Cap 1.36B
Revenue (ttm) 87.37M
Net Income (ttm) -301.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -345.36%
Debt to Equity Ratio 0.00
Volume 1,563,200
Avg Vol 1,882,666
Day's Range N/A - N/A
Shares Out 109.82M
Stochastic %K 43%
Beta -0.34
Analysts Strong Sell
Price Target $20.33

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fix...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 682 0917
Website: amylyx.com
Address:
43 Thorndike Street, Cambridge, United States
ajmore
ajmore Nov. 14 at 3:24 PM
$AMLX Pharma bidding battle field intensifying! nice article by Dow Jones Institutional News.
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 14 at 2:36 PM
$RXRX Good Morning 💎 s ! $AMLX $SANA $VVPR
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 13 at 9:01 PM
$AMLX What a 💎 green today!! Bound for $30 plus🚀
0 · Reply
I_AM_GHEY
I_AM_GHEY Nov. 13 at 7:43 PM
$AMLX Holding strong in a sea of deep red today. 2026 is going to be a pivotal year for AMLX if they can stick to their timeline and hit goals. Getting Phase 3 LUCIDITY data for PBH in Q3 2026 and getting avexitide on the market in 2027 will be so big for this company. In the short term, there is a P1 data readout for ALS happening in December but I don't expect that will pump the stock until it gets approved for a larger P2 study. This study was fast-tracked back in June so there is an inherent level of confidence that it will move on to P2 without any limitations. Going to be an exciting 12 months ahead!
0 · Reply
ajmore
ajmore Nov. 13 at 6:18 PM
$AMLX according to chatgpt stats top line data release before/at conference have an average return of 10-40%. We are approaching date very fast.
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 13 at 2:18 PM
$RXRX Good Morning my 💎 s☕️ $SANA $AMLX $PLTY
0 · Reply
ajmore
ajmore Nov. 13 at 11:21 AM
$AMLX Its normal to short high momentum stocks, check the other high momentum. buy these startegies are short term and then they have to cover especially with news imminent from the AMX0114. no cinspiracy, nothing! in fact, shorts help yo fuel the squeeze.
1 · Reply
SilentBull69
SilentBull69 Nov. 12 at 9:11 PM
$NCLH $CCL $AMLX $JBLU What kind of alternate reality does the stock market exist in anymore? We have gone up 1000 points on the DOW in the last couple days …..but practically EVERY Stock I own is either down or not moving …mostly down how is this possible? We all know that JP Morgan Chase, and groups like Citadel are shorting the living hell out of practically every company out there This is criminal at this point ….and something needs to be done to stop all this insanity and corruption in our stock market, this naked shorting, illegal naked shorting and other tools that these hedge funds have been using along …with the algorithms that is running our market today , are completely irrational at this point …and needs to be stopped before we don’t have a stock market anymore that any retail personnel will believe in. 
1 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 12 at 2:06 PM
$RXRX Good Morning 💎 s☕️ $AMLX $SANA $VVPR $PLTY
0 · Reply
Quantumup
Quantumup Nov. 12 at 1:19 PM
JonesTrading⬆️ $RZLT's PT to $14 from $12 and reiterated at a Buy rating. $ZLDPF $CRNX $AMLX Here's what JonesTrading had to say in its note:
0 · Reply
Latest News on AMLX
Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery

Jul 14, 2025, 2:15 PM EDT - 4 months ago

Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery


Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market

Jun 24, 2025, 2:59 PM EDT - 5 months ago

Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market


ajmore
ajmore Nov. 14 at 3:24 PM
$AMLX Pharma bidding battle field intensifying! nice article by Dow Jones Institutional News.
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 14 at 2:36 PM
$RXRX Good Morning 💎 s ! $AMLX $SANA $VVPR
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 13 at 9:01 PM
$AMLX What a 💎 green today!! Bound for $30 plus🚀
0 · Reply
I_AM_GHEY
I_AM_GHEY Nov. 13 at 7:43 PM
$AMLX Holding strong in a sea of deep red today. 2026 is going to be a pivotal year for AMLX if they can stick to their timeline and hit goals. Getting Phase 3 LUCIDITY data for PBH in Q3 2026 and getting avexitide on the market in 2027 will be so big for this company. In the short term, there is a P1 data readout for ALS happening in December but I don't expect that will pump the stock until it gets approved for a larger P2 study. This study was fast-tracked back in June so there is an inherent level of confidence that it will move on to P2 without any limitations. Going to be an exciting 12 months ahead!
0 · Reply
ajmore
ajmore Nov. 13 at 6:18 PM
$AMLX according to chatgpt stats top line data release before/at conference have an average return of 10-40%. We are approaching date very fast.
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 13 at 2:18 PM
$RXRX Good Morning my 💎 s☕️ $SANA $AMLX $PLTY
0 · Reply
ajmore
ajmore Nov. 13 at 11:21 AM
$AMLX Its normal to short high momentum stocks, check the other high momentum. buy these startegies are short term and then they have to cover especially with news imminent from the AMX0114. no cinspiracy, nothing! in fact, shorts help yo fuel the squeeze.
1 · Reply
SilentBull69
SilentBull69 Nov. 12 at 9:11 PM
$NCLH $CCL $AMLX $JBLU What kind of alternate reality does the stock market exist in anymore? We have gone up 1000 points on the DOW in the last couple days …..but practically EVERY Stock I own is either down or not moving …mostly down how is this possible? We all know that JP Morgan Chase, and groups like Citadel are shorting the living hell out of practically every company out there This is criminal at this point ….and something needs to be done to stop all this insanity and corruption in our stock market, this naked shorting, illegal naked shorting and other tools that these hedge funds have been using along …with the algorithms that is running our market today , are completely irrational at this point …and needs to be stopped before we don’t have a stock market anymore that any retail personnel will believe in. 
1 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 12 at 2:06 PM
$RXRX Good Morning 💎 s☕️ $AMLX $SANA $VVPR $PLTY
0 · Reply
Quantumup
Quantumup Nov. 12 at 1:19 PM
JonesTrading⬆️ $RZLT's PT to $14 from $12 and reiterated at a Buy rating. $ZLDPF $CRNX $AMLX Here's what JonesTrading had to say in its note:
0 · Reply
SilentBull69
SilentBull69 Nov. 11 at 9:21 PM
$AMLX AMLX now has a massive $344 million war chest that they say will go through 2028 AMLX did a public offering last September and raised $191 million ..adding 20,125,000 (20 million) shares to the outstanding share count at $10/share. Which is still very low. “In September 2025, Amylyx Pharmaceuticals (AMLX) conducted a public offering that resulted in net proceeds of approximately $191 million. The initial announcement priced the offering at $175 million, issuing 17,500,000 additional shares of common stock at a public offering price of $10.00 per share. The company also granted the underwriters a 30-day option to purchase up to an additional 2,625,000 shares. The final net proceeds of $191 million suggest this option was likely exercised, resulting in a total of 20,125,000 shares added to the outstanding share account (17,500,000 initial shares plus 2,625,000 option shares). These shares were issued from the company's authorized but previously unissued shares. “ 
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 11 at 8:47 PM
$AMLX 🚀
0 · Reply
AbovetheGreenLine
AbovetheGreenLine Nov. 11 at 8:23 PM
Swing Trade Buy on the Close for Amylyx Pharma.$AMLX. https://abovethegreenline.com/wp-content/uploads/2021/01/ST-1.jpg https://zpr.io/DKeG
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 11 at 5:20 PM
$RXRX My 💎 s this $AMLX $SANA All bound for $30 plus 🚀🤑
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 11 at 4:14 PM
$AMLX Good Morning ☕️ 3X from here for starters ☕️🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 11 at 4:02 AM
$AMLX Yeah “Pleased with Avexitide Phase 3 “
0 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 11 at 3:43 AM
$AMLX AMX114 for ALS Early Cohort data anytime! 🚀
0 · Reply
ajmore
ajmore Nov. 10 at 9:53 PM
$AMLX presentation live... from the transcript: ...we are very pleased with the conduct [of the phase 3 trial] so far.
1 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 10 at 8:38 PM
$AMLX $30 PT 🚀
0 · Reply
ajmore
ajmore Nov. 10 at 5:53 PM
$AMLX presenting at Guggenheim in 3.5 hrs.
1 · Reply
LoveRetailFroth
LoveRetailFroth Nov. 10 at 2:50 PM
$RXRX Good Morning ☕️ $SANA $AMLX $PLTY
1 · Reply
ajmore
ajmore Nov. 10 at 12:21 PM
$AMLX $NVO pulls out from the bidding war with $PFE over $MTSR . Sector heating up, and it's right to consider companies with own molecules and patents as ligit potential acquisitions targets.
0 · Reply